H.R. 1192, National Clinical Care Commission Act

H.R. 1192

National Clinical Care Commission Act

Rep. Pete Olson

November 14, 2016 (114th Congress, 2nd Session)

Staff Contact
John Huston

Floor Situation

On­­­­ Monday, November 14, 2016, the House will begin consideration of H.R. 1192, National Clinical Care Commission Act, under suspension of the rules. H.R. 1192 was introduced on March 2, 2015, by Rep. Pete Olson (R-TX) and was referred to the Committee on Energy and Commerce, which ordered the bill reported by voice vote on September 21, 2016.

Bill Summary

H.R. 1192 establishes a clinical care commission to evaluate and recommend solutions regarding better coordinating federal programs related to complex metabolic or autoimmune disorders, a disease resulting from insulin deficiency or resistance, or complications caused by any such disease. The bill requires the Commission to report its recommendations not later than three years after its first meeting. The bill sunsets the Commission at the end of fiscal year 2019.


The federal government supports research and development (R&D) that is conducted by a wide variety of performers, including federally owned and operated laboratories, universities, private companies, and other research institutions. This includes funding for the National Institutes of Health (NIH), which is the focal point for federal health research. An agency of the Department of Health and Human Services (HHS), it uses its $30 billion plus budget to support more than 300,000 scientists and research personnel working at over 2,500 institutions across the United States and abroad, as well as to conduct biomedical and behavioral research and research training at its own facilities. H.R. 1192 will establish a commission that will attempt to better utilize existing federal funding for complex metabolic or autoimmune disorders including diabetes, which includes some funding administered by NIH.


A Congressional Budget Office (CBO) cost estimate is not currently available.

Additional Information

For questions or further information please contact John Huston with the House Republican Policy Committee by email or at 6-5539.